Table 4.

List of drugs or monoclonal antibodies which WHO has advised against, and the corresponding number of National Guidelines that (as a percentage of total) recommended these in late 2022

Drug or monoclonal antibody	In late 2022, the number of NGs (%) recommending these medicines which WHO has advised against
Hydroxychloroquine or chloroquine	19 (17%)
Favipiravir	16 (15%)
Vitamins and/or zinc	15 (14%)
Lopinavir–ritonavir	14 (13%)
Azithromycin	12 (11%)
Anakinra	9 (8%)
Convalescent plasma or immunoglobulin	9 (8%)
Interferons	5 (5%)
Inhaled budesonide	4 (4%)

NGs, national guidelines.